HUP0001316A3 - Method for the detection and localization of malignant human tumours - Google Patents
Method for the detection and localization of malignant human tumoursInfo
- Publication number
- HUP0001316A3 HUP0001316A3 HU0001316A HUP0001316A HUP0001316A3 HU P0001316 A3 HUP0001316 A3 HU P0001316A3 HU 0001316 A HU0001316 A HU 0001316A HU P0001316 A HUP0001316 A HU P0001316A HU P0001316 A3 HUP0001316 A3 HU P0001316A3
- Authority
- HU
- Hungary
- Prior art keywords
- localization
- detection
- malignant human
- human tumours
- tumours
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 230000004807 localization Effects 0.000 title 1
- 230000003211 malignant effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/085—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being neurotensin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97200297 | 1997-02-03 | ||
PCT/US1998/001964 WO1998033531A1 (en) | 1997-02-03 | 1998-02-02 | Method for the detection and localization of malignant human tumours |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0001316A2 HUP0001316A2 (hu) | 2000-09-28 |
HUP0001316A3 true HUP0001316A3 (en) | 2001-10-29 |
Family
ID=26146106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0001316A HUP0001316A3 (en) | 1997-02-03 | 1998-02-02 | Method for the detection and localization of malignant human tumours |
Country Status (11)
Country | Link |
---|---|
US (2) | US6312661B1 (hu) |
EP (1) | EP0968001B1 (hu) |
JP (1) | JP2001511152A (hu) |
AT (1) | ATE253381T1 (hu) |
AU (1) | AU728712C (hu) |
CA (1) | CA2279530C (hu) |
DE (1) | DE69819478T2 (hu) |
HU (1) | HUP0001316A3 (hu) |
IL (1) | IL131386A0 (hu) |
NO (1) | NO993846L (hu) |
WO (1) | WO1998033531A1 (hu) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3340699B2 (ja) * | 1998-06-05 | 2002-11-05 | 東京瓦斯株式会社 | 膵外分泌機能診断剤 |
US7232559B1 (en) | 1999-06-04 | 2007-06-19 | Tokyo Gas Company Limited | Diagnostic agents for pancreatic exocrine function |
AU2119101A (en) * | 1999-10-22 | 2001-05-08 | Insight Neuroimaging Systems, Llc | Ligand chelated paramagnetic mri contrast agents |
US7630907B2 (en) * | 2001-10-30 | 2009-12-08 | Biodose, Llc | Algorithm and program for the handling and administration of radioactive pharmaceuticals |
US8175890B2 (en) * | 2001-10-30 | 2012-05-08 | Biodose, Llc | Pharmacy based method and algorithm for handling of radioactive pharmaceuticals and generating of reports therefrom |
US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
EP1587944A4 (en) | 2002-03-01 | 2007-03-21 | Dyax Corp | KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
US20040039241A1 (en) * | 2002-05-29 | 2004-02-26 | Biodose Llc | Integrated distribution and communication process and algorithm for providing, handling, distributing or generating reports regarding radioactive pharmaceuticals |
WO2004009614A2 (en) * | 2002-07-24 | 2004-01-29 | The Salk Institute For Biological Studies | Receptor (sstr4)- selective somatostatin analogs |
GR1004637B (el) * | 2003-04-04 | 2004-07-23 | Βιομεντικααλαιφασαιενσισαανωνυμηαεταιριααφαρμακευτικωναπροιοντωναα | Συνθεσηαβιολογικηακαιαπροκλινικηααξιολογησηααναλογωνανευροτενσινησα}@@bατροποποιημενωναμεαπαραγωγαατουα@ϊ@τετρααζαενδεκανιουα}@ϊ@tetraazaundecanebακαιαεπισημασμενωναμεατεχνητιο@mα}αηαλλααραδιονουκλιδιαατουατεχνητιουbαη@καιαρηνιο@ϊϊα}΄ηααλλααραδιονουκλιδιαατουαρηνιουbαγιααεφαρμογηαστηναογκολογιαα |
WO2005027981A1 (en) * | 2003-09-17 | 2005-03-31 | Board Of Regents, The University Of Texas System | Mechanism-based targeted pancreatic beta cell imaging and therapy |
US7507547B2 (en) * | 2004-09-09 | 2009-03-24 | University Of Massachusetts | Screening assays for antioxidants and antiproliferative compounds |
US20060062729A1 (en) * | 2004-09-09 | 2006-03-23 | Carraway Robert E | Enhanced ligand binding to neurotensin receptors |
US8586043B2 (en) | 2009-01-07 | 2013-11-19 | Inserm ( Institut National De La Sante Et De La Recherche Medicale) | Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1 |
US9809624B2 (en) * | 2009-07-16 | 2017-11-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors |
US8378134B2 (en) | 2009-09-30 | 2013-02-19 | General Electric Company | Hydroxylated contrast enhancement agents |
EP2740726A1 (en) | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
EP2954933A1 (en) | 2014-06-10 | 2015-12-16 | 3B Pharmaceuticals GmbH | Conjugate comprising a neurotensin receptor ligand |
WO2015188934A1 (en) | 2014-06-10 | 2015-12-17 | 3B Pharmaceuticals Gmbh | Conjugate comprising a neurotensin receptor ligand and use thereof |
EP2954934A1 (en) | 2014-06-11 | 2015-12-16 | 3B Pharmaceuticals GmbH | Conjugate comprising a neurotensin receptor ligand and use thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687680A1 (fr) * | 1992-02-20 | 1993-08-27 | Centre Nat Rech Scient | Procede de marquage de proteines et de peptides par acylation de leur fonction alpha aminee par un reactif comportant une fonction carboxylique activee. |
EP0636032A1 (en) * | 1992-03-25 | 1995-02-01 | Mallinckrodt Medical, Inc. | Method of intraoperatively detecting and locating tumoral tissues |
CA2086453A1 (en) * | 1992-12-30 | 1994-07-01 | Mcgill University | Marker for neurotensin receptor |
DE4337599A1 (de) * | 1993-11-01 | 1995-05-04 | Diagnostikforschung Inst | Metallbindende cysteinfreie Peptide für Diagnose und Therapie, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
EP0752873A4 (en) * | 1994-02-18 | 2002-05-15 | Mallinckrodt Inc | MARKED PEPTIDE COMPOUNDS |
FR2720066B1 (fr) * | 1994-05-20 | 1996-06-28 | Rhone Poulenc Rorer Sa | Peptides antagonistes de la neurotensine. |
FR2722193B1 (fr) * | 1994-07-08 | 1996-10-04 | Sanofi Sa | Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant |
WO1996023527A1 (en) * | 1995-02-03 | 1996-08-08 | Mallinckrodt Medical, Inc. | Method for the detection and localization of malignant human tumours |
-
1998
- 1998-02-02 HU HU0001316A patent/HUP0001316A3/hu unknown
- 1998-02-02 US US09/355,869 patent/US6312661B1/en not_active Expired - Lifetime
- 1998-02-02 IL IL13138698A patent/IL131386A0/xx unknown
- 1998-02-02 DE DE69819478T patent/DE69819478T2/de not_active Expired - Lifetime
- 1998-02-02 AT AT98904839T patent/ATE253381T1/de not_active IP Right Cessation
- 1998-02-02 AU AU62622/98A patent/AU728712C/en not_active Ceased
- 1998-02-02 WO PCT/US1998/001964 patent/WO1998033531A1/en not_active Application Discontinuation
- 1998-02-02 CA CA002279530A patent/CA2279530C/en not_active Expired - Lifetime
- 1998-02-02 EP EP98904839A patent/EP0968001B1/en not_active Expired - Lifetime
- 1998-02-02 JP JP53317698A patent/JP2001511152A/ja active Pending
-
1999
- 1999-08-10 NO NO993846A patent/NO993846L/no not_active Application Discontinuation
-
2001
- 2001-11-05 US US09/985,672 patent/US20020155064A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2001511152A (ja) | 2001-08-07 |
NO993846L (no) | 1999-09-09 |
AU6262298A (en) | 1998-08-25 |
US6312661B1 (en) | 2001-11-06 |
US20020155064A1 (en) | 2002-10-24 |
HUP0001316A2 (hu) | 2000-09-28 |
AU728712C (en) | 2001-07-19 |
CA2279530A1 (en) | 1998-08-06 |
AU728712B2 (en) | 2001-01-18 |
CA2279530C (en) | 2009-04-28 |
IL131386A0 (en) | 2001-01-28 |
DE69819478T2 (de) | 2004-09-02 |
EP0968001B1 (en) | 2003-11-05 |
WO1998033531A1 (en) | 1998-08-06 |
NO993846D0 (no) | 1999-08-10 |
ATE253381T1 (de) | 2003-11-15 |
EP0968001A1 (en) | 2000-01-05 |
DE69819478D1 (de) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0001316A3 (en) | Method for the detection and localization of malignant human tumours | |
GB2310930B (en) | Improved dipole moment detector and localizer | |
AU3154297A (en) | Materials and methods for detection of breast cancer | |
HUP0002095A3 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
AU4317799A (en) | Method and system for the computerized assessment of breast cancer risk | |
EP0903590A4 (en) | RADIATION DETECTING DEVICE AND METHOD FOR PRODUCING THIS DEVICE | |
AU4473596A (en) | Methods of human prostate cancer diagnosis | |
ZA982968B (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
GB2318734B (en) | Methods of preventing breast cancer | |
AU8259798A (en) | Method for detection of breast cancer | |
AU8068198A (en) | Methods for treating human cancers | |
MD798F1 (en) | Method of the mamma cancer treatment | |
ZA9291B (en) | Process for the detection and localization of cancer | |
AU5672000A (en) | Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereof | |
IL127868A0 (en) | Localization and tracking | |
GB9812550D0 (en) | Tumour therapy and imaging | |
IL132531A0 (en) | Detection and therapy of tumors | |
AU5939898A (en) | Agent for the pre-symptomatic detection, prevention and treatment of breast cancer in humans | |
AU4068897A (en) | Human induced tumor protein | |
IL136210A0 (en) | Reagent for tumor therapy and/or imaging | |
GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
AU4402497A (en) | Methods and means for the treatment of malignancies | |
GB9624800D0 (en) | Methods of preventing breast cancer | |
GB9716787D0 (en) | Materials and methods for the diagnosis and treatment of breast cancer | |
AU6549398A (en) | Immune complexes and methods of detection and treatment thereof |